Hirakata H, Iseki K, Onoyama K, Kumagai H, Fujimi S, Omae T
Clin Nephrol. 1983 Feb;19(2):87-91.
The long-term effect of treatment with captopril was observed in 7 hypertensive patients on maintenance hemodialysis who had been refractory to combined antihypertensive therapy with propranolol and hydralazine. Captopril showed a potent hypotensive effect in all the subjects throughout the study period of 6 months. The blood-pressure reduction during treatment with captopril was associated with a decrease in total peripheral resistance. Cardiac index increased significantly due to a significant increment in heart rate at the 6th month. Plasma renin activity increased significantly at the 3rd month, whereas it decreased at the 6th month. No significant correlation was observed between the blood-pressure response and the pre-treatment level of plasma renin activity.
对7例维持性血液透析的高血压患者进行观察,这些患者对普萘洛尔和肼屈嗪联合抗高血压治疗无效,以观察卡托普利治疗的长期效果。在整个6个月的研究期间,卡托普利在所有受试者中均显示出强效的降压作用。卡托普利治疗期间的血压降低与总外周阻力的降低有关。由于第6个月心率显著增加,心脏指数显著升高。血浆肾素活性在第3个月显著升高,而在第6个月降低。血压反应与治疗前血浆肾素活性水平之间未观察到显著相关性。